Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now mentions Tuberculosis and includes a link to the Genetic and Rare Diseases Information Center. The revision tag has been updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check20 days agoChange DetectedThe only visible change is a footer revision update from v3.4.0 to v3.4.1, with no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedUI updates include showing the glossary toggle and minor wording changes such as capitalization in 'Last Update Submitted' and 'QC Criteria' as well as a version reference updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. No changes were made to the study details or page content.SummaryDifference0.0%

- Check63 days agoChange DetectedNew location sections were added for Illinois, New York, North Carolina, Pennsylvania, Texas, Gauteng, West Cape, and Patumwan, replacing the previous location blocks. The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure footer was removed.SummaryDifference0.8%

- Check91 days agoChange DetectedThe only change is a version update: Revision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.